GSK vows to stop paying doctors to promote drugs2013-12-18
British drug company GlaxoSmithKline said Tuesday it would stop paying doctors to promote its products at speaking engagements and scrap individual sales targets, months after its ethics were challenged by a bribery scandal in China.

Former China GSK boss remains in China assisting in probe2013-10-17
Mark Reilly, GlaxoSmithKline's former head of operations in China, is helping Chinese anti-corruption officials who are investigating allegations of extensive bribery by the drugmaker.

GSK's threat of China withdrawal, a bargaining chip?2013-09-09
GlaxoSmithKline is considering whether to pull out of China, where a criminal investigation has left the company facing a potential 20bn-yuan (2bn-pound) fine and the severance of ties with major hospitals.

Collaborating from within, foreign drug dealers find their way into China2013-09-06
An increasing number of international drug dealers are finding themselves Chinese girlfriends to make it easier to conduct their "business" in China.

Eli Lilly mired in bribery scandal2013-08-23
Pharmaceutical giant Eli Lilly, one of the world's biggest insulin producers, has been accused of systematically bribing physicians and hospitals in Shanghai to promote the sales of two of its insulin products, according to media reports.

Health authorities probe bribes to doctors2013-08-12
Health authorities have started to probe the alleged 1.69 million yuan ($276,000) in bribes from Sanofi-Aventis to 503 doctors in Beijing, Shanghai, Hangzhou and Guangzhou.